BNGO (STOCKS)
Bionano Genomics, Inc. Common Stock
$1.169800
+0.009800 (+0.84%)
Prev close: $1.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Albert A. Luderer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.31M
- Employees
- 100
- P/E (TTM)
- -0.23
- P/B (TTM)
- 0.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.76 | $-0.90 | +0.1376 | +15.33% |
|
Dec 2025 (Q4)
|
$-0.03 | $-1.43 | +1.3980 | +97.90% |
|
Sep 2025 (Q3)
|
$-1.59 | $-1.95 | +0.3582 | +18.39% |
|
Jun 2025 (Q2)
|
$-1.99 | $-2.46 | +0.4733 | +19.21% |
Financial Statements
| Revenues | $28.74M |
| Benefits Costs and Expenses | $60.27M |
| Cost Of Revenue | $15.24M |
| Costs And Expenses | $46.27M |
| Gross Profit | $13.50M |
| Nonoperating Income/Loss | $1.24M |
| Operating Expenses | $46.27M |
| Selling, General, and Administrative Expenses | $34.13M |
| Research and Development | $12.14M |
| Operating Income/Loss | -$32.77M |
| Income/Loss From Continuing Operations After Tax | -$31.60M |
| Income/Loss From Continuing Operations Before Tax | -$31.53M |
| Income Tax Expense/Benefit | $69.00K |
| Net Income/Loss | -$31.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.37 |
| Diluted Earnings Per Share | -$4.37 |
| Basic Average Shares | 21,374,000 |
| Diluted Average Shares | 21,374,000 |
| Assets | $64.80M |
| Current Assets | $38.98M |
| Inventory | $7.69M |
| Other Current Assets | $31.29M |
| Noncurrent Assets | $25.83M |
| Fixed Assets | $14.04M |
| Intangible Assets | $3.01M |
| Other Non-current Assets | $8.78M |
| Liabilities | $27.34M |
| Current Liabilities | $21.23M |
| Accounts Payable | $5.06M |
| Wages | $2.43M |
| Other Current Liabilities | $13.74M |
| Noncurrent Liabilities | $6.11M |
| Equity | $37.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $37.46M |
| Liabilities And Equity | $64.80M |
| Net Cash Flow From Operating Activities | -$19.30M |
| Net Cash Flow From Operating Activities, Continuing | -$19.30M |
| Net Cash Flow From Investing Activities | $6.78M |
| Net Cash Flow From Investing Activities, Continuing | $6.78M |
| Net Cash Flow From Financing Activities | $13.81M |
| Net Cash Flow From Financing Activities, Continuing | $13.81M |
| Exchange Gains/Losses | $3.00K |
| Net Cash Flow | $1.29M |
| Net Cash Flow, Continuing | $1.28M |
| Comprehensive Income/Loss | -$31.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.60M |
| Other Comprehensive Income/Loss | -$24.72M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.00K |